首页> 外文会议>International Conference on Materials Science and Manufacturing >Cytotoxic Effects of Transforming Growth Factor-α Conjugated with Cytotoxin Saporin on proliferating vascular smooth muscle cells
【24h】

Cytotoxic Effects of Transforming Growth Factor-α Conjugated with Cytotoxin Saporin on proliferating vascular smooth muscle cells

机译:将生长因子 - α与细胞毒素Saporin缀合在增殖血管平滑肌细胞中的细胞毒性作用

获取原文

摘要

Objective: To testify the special cytotoxicity of TGFα-SAP on proliferating vascular smooth muscle cells and endothelial cells. Methods: Conjugation of saporin to TGFα was accomplished after derivatization of saporin and TGFα with N-succinimidyl-3 (2-pyridyldithio) proprionate and final purification of the conjugate was achieved within Eppendorf Centrifugal Filter Cytotoxicity assays were measured by cell count. The studies of influence of TGFα-SAP on values of Thymidine and leucine incorporation into SMCs and ECs were measured by 3H-thymidine uptake and 3H-leucine uptake, respectively. and receptor competition studies of TGFα-SAP are measured by adding excess TGFα in SMCs exposed for TGFα-SAP. Results: Cytotoxicity assays testified TGFα-SAP conjugate could inhibit remarkably proliferation of SMCs in culture. The values of thymidine of TGFα-SAP group (10~(-9)M and 10~(-7)M) in comparison significantly decreased to 60.9% and 56.0% of the control group respectively, suggesting that cellular DNA synthesis obviously decreased as TGFα-SAP was added. But Saporin did not affect cellular DNA synthesis at higher level. The rate of 3H-leucine incorporation of TGFα-SAP group significantly decreased to 47.3% of the control group, suggesting that SMCs protein synthesis obviously decreased as TGFα-SAP was added. But TGFα-SAP at the same level did not affect DNA synthesis and protein synthesis of ECs compared with the control group. Conclusion: The results indicated that TGFα-SAP possesses the more effective cytotoxicity than Saporin and the more special citotoxicity on proliferating vascular smooth muscle cells than on proliferating endothelial cells.
机译:目的:鉴于TGFα-SAP的特殊细胞毒性对增殖血管平滑肌细胞和内皮细胞的特殊细胞毒性。方法:通过N-琥珀酰亚胺基-3(2-吡啶二硫基)的衍生化和TGFα的衍生化衍生衍生物缀合Saporin至TGFα的缀合物,并通过细胞计数在EPPendorf离心过滤器细胞毒性测定中获得缀合物的最终纯化。通过3H-胸苷摄取和3H-亮氨酸摄取,测量TGFα-SAP对胸苷和亮氨酸掺入SMC和ECS值的影响。通过在暴露于TGFα-SAP的SMC中添加过量的TGFα来测量TGFα-SAP的受体竞争研究。结果:鉴定TGFα-SAP缀合物的细胞毒性测定可以抑制培养中SMC的显着增殖。相比之下,TGFα-SAP组(10〜(-9)m和10〜(-7)m)的胸苷的值分别显着降至对照组的60.9%和56.0%,表明细胞DNA合成明显减少为加入TGFα-SAP。但Saporin在更高水平下没有影响细胞DNA合成。 TGFα-SAP组的3H-亮氨酸掺入的速率显着降低至对照组的47.3%,表明在加入TGFα-SAP时,SMC蛋白合成明显降低。但与对照组相比,同一水平的TGFα-SAP不会影响ECS的DNA合成和蛋白质合成。结论:结果表明,TGFα-SAP具有比Saporin更有效的细胞毒性,并且更特殊的岩虫性比增殖内皮细胞增殖血管平滑肌细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号